Optimum Technologies

Next Stage Solutions

Mass Device

MEDS (Medical Electronic Device Solutions) is a must-read publication for the Medical Device Developers. Our vision is to cooperate with leading medical device manufacturers and community groups to educate and promote the best practices to help medical device manufacturers to develop and produce the best medical products. We would help facilitate the building of the medical eco-systems / communities worldwide.

Get Involved!

  • MDG thrives because of the dedication of its volunteer members. Contact our Committee Chairs to see where your unique skills can best help MDG grow.

  • Ready to help, but not sure where your effort will count? Volunteering is an excellent way to network with other professionals in the MedDev Group community! Take a look at our Volunteer Signup Form for ideas on ways to take part in this growing, vital organization!

  • Click here to review our committee activities.

Polls & Surveys

Tell us what you think! We welcome your feedback - send your thoughts and comments to info@mdgboston.org.

Twitter

Join MDG on Twitter

 

Upcoming Events

Quick Links to Event Info & Registration:

Brief Descriptions of Events Below:


Medical Device Workshop: Working Together – Keeping Informed

Program Description
The Medical Development Group (MDG) is collaborating with the FDA New England District Office in presenting a half day seminar that will address the following:

  • Doing Business in a Regulated Industry - Preparing for an FDA Review, with an overview of this important activity together with presentations from FDA Compliance Officers on Quality System Inspection Technique (QSIT) Inspections; Complaint Handling and What You Need to Know about Recalls.
  • Meeting FDA Guidelines in Implementing Unique Device Identification (UDI) which will be in effect for Class III products beginning on Sept. 24, 2014, with Class II and Class I implementations required over the next several years.
  • Issues in addressing Medical Device Counterfeit Parts. This is a growing and serious problem, particularly as supply chains grow longer and more complex.

The FDA Review Session will be conducted by FDA Management and Compliance Officers from the New England district offices. The Counterfeiting and UDI sessions will use experts from MDG.

Who Should Attend

The seminar is targeted at medical device and life sciences companies in the New England area. Space is limited so early registration is strongly recommended.


In Vivo Optical Cancer Detection: 20 years of Lessons Learned & 20 Years of Future Promise

Program Description
Optical cancer detection has been a focal point of development in the medical community for over 20 years.  There have been many attempts at developing and commercializing devices with varying degrees of success.  This month’s panel of experts is actively engaged and on the clinical frontier in optical cancer detection. The presentations will cover the history, present, and future of in vivo optical cancer detection.

  • Randal Chinnock, CEO of Optimum Technologies Inc., will moderate the discussions and present historical case studies of in-vivo optical cancer detection over the past 20 years, and reasons why so few detection/diagnostic devices have actually had significant clinical impact.
  • Dr. Melissa Suter, Assistant Professor at Harvard Medical School, will discuss the outlook for what will happen with in-vivo optical cancer detection in the next twenty years from an academic perspective.  The discussion will focus on promising innovations in technology and engineering in the academic world.
  • Joseph Williams, Vice President of Global Marketing for Caliber Imaging and Diagnostics Inc. will present the view of the future of in-vivo optical cancer detection from an industry standpoint.  The myriad of challenges the industry will face in commercializing emerging technologies will be discussed.

Who Should Attend

Any executive, manager or professional in the medical device or biotech/pharma arena who wants to hear:

  • How the longtime promise of optical cancer detection has come to fruition with new devices that are improving patient care and changing the marketplace.
  • About arising opportunities plus technical and competitive challenges.
  • How this diagnostic technology fits into an evolving cost/benefit-focused healthcare landscape and where the field is headed.


Upcoming Events from MDG Partners



News & Announcements


Email Newsletter Signup

 
If you aren't a member but would like to
get email meeting announcements,
fill in the box below.
 
Email:
 

Homepage Site map Terms & Conditions Privacy Policy
 
website by: